Missouri's expanded Medicaid mammography coverage leads to a 45% increase in screening rates and higher adoption of advanced imaging technologies, enhancing early breast cancer detection and preventive care.
The One Big Beautiful Bill Act (OBBBA) establishes statutory caps on state-directed payments in Medicaid managed care, centralizing federal control and impacting value-based payment reforms. CMS expected to issue guidance on implementation.
Explore how the One Big Beautiful Bill is transforming U.S. healthcare payment models, Medicaid work requirements, ACA subsidies, and rural hospital funding dynamics with expert analysis from Marwood Group.
Minnesota's new law introduces phased Medicaid cuts affecting eligibility, healthcare funding, and rural hospitals, with significant administrative and enrollment impacts.
Georgia faces significant health insurance premium hikes and nursing home closures due to recent federal budget cuts, raising concerns over Medicaid funding and healthcare access in the state.
Major U.S. health insurers face rising medical costs driven by specialty drug spending and upcoding, impacting earnings and Medicaid, ACA market dynamics in 2025.
New federal law cuts $911B from Medicaid and ACA, increasing uninsured rates and insurance premiums. State budgets and hospitals face rising uncompensated care costs.
An overview of expanding health system-owned insurance plans across the U.S. highlighting integrated care, diverse product offerings, and enhanced provider networks.
CMS is considering a pilot program to cover GLP-1 drugs for obesity under Medicare and Medicaid, reversing earlier policy. This evolving coverage changes obesity drug access for patients and payers.
The Trump administration proposes a Medicare and Medicaid pilot program for covering GLP-1 weight loss drugs, marking a key shift in healthcare policy and potential budget impacts.
